The secret of how the cold sore virus (herpes simplex virus 1) manages to persist for a lifetime in the human body may have been cracked by US scientists. – Now that Duke University Medical Center scientists have figured out how the virus that causes cold sores hides out, they may have a way to wake it up and kill it.
Jo’s Trust cervical cancer charity welcomes Department of Health’s announcement about HPV vaccine Cervarix. – The UK’s leading cervical cancer charity, Jo’s Trust, has welcomed the UK’s Department of Health’s announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.
A new avenue to possibly prevent HIV infection of the penis – topical estrogen to the human penis increased the thickness of the natural keratin layer on the skin, which could prevent HIV from infecting the male. – Topical oestrogen applied to the human penis could stop the spread of HIV, revealed by Australian researchers at the University of Melbourne.
New research into the causes of cervical cancer appears to lend weight to the promise of a potential early detection method that could help prevent the disease. – Persistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide, revealed by researchers from the University of North Carolina at Chapel Hill.
New ‘OPAL Therapy’ presents simple, cost-effective method of treating HIV infection – Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.
U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12. – U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it’s incumbent upon the healthcare community to work to improve mom’s acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children’s Hospital Medical Center who conducted the study.
A new vaccine that apparently can provide long-lasting protection for pathogenic bird flu, H5N1, and its mutations, has been developed by Purdue researchers in collaboration with the Centers for Disease Control and Prevention. – A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
The Food and Drug Administration has approved the GlaxoSmithKline (NYSE:GSK) vaccine Rotarix for use in infants. – The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 weeks of age.
Expansion of a monocyte subset in HIV patients could serve as a biomarker for progression of the disease. – An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University, reported in the March issue of AIDS Research and Human Retroviruses.
STMicroelectronics and Veredus Laboratories Launch Market?s First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need – Following the success of the evaluation trials conducted at the prestigious National University Hospital of Singapore, Veredus Laboratories and STMicroelectronics (NYSE: STM) announced the commercial availability of VereFlu, a portable lab-on-chip application for rapid detection of all major influenza types at the point of need.
New Zealand AIDS Foundation is welcoming the reduction in overall numbers of new HIV diagnoses in 2007, in particular that diagnoses among gay and bisexual men have remained equivalent to 2006 levels. – The New Zealand AIDS Foundation is welcoming the reduction in overall numbers of new HIV diagnoses in 2007, in particular that diagnoses among gay and bisexual men have remained equivalent to 2006 levels.
A US study found that one in four teenage girls aged 14 to 19 has a sexually transmitted disease (STD). Nearly half the African-Americans in the study were infected by one of the diseases. – A US study found that one in four teenage girls aged 14 to 19 has a sexually transmitted disease (STD). Nearly half the African-Americans in the study were infected by one of the diseases. The survey, part of the National Health and Nutrition Examination Survey, did not ask about syphilis or gonorrhea, so it is likely the STD rates are actually higher.
